KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Buildings (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Buildings for 11 consecutive years, with $7.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Buildings rose 10.47% to $7.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $7.3 billion, a 10.47% increase, with the full-year FY2025 number at $7.3 billion, up 10.47% from a year prior.
  • Buildings was $7.3 billion for Q4 2025 at Bristol Myers Squibb, up from $7.1 billion in the prior quarter.
  • In the past five years, Buildings ranged from a high of $7.3 billion in Q4 2025 to a low of $5.6 billion in Q1 2021.
  • A 5-year average of $6.3 billion and a median of $6.2 billion in 2023 define the central range for Buildings.
  • Peak YoY movement for Buildings: decreased 4.04% in 2021, then rose 10.47% in 2025.
  • Bristol Myers Squibb's Buildings stood at $5.9 billion in 2021, then grew by 0.39% to $5.9 billion in 2022, then rose by 9.71% to $6.5 billion in 2023, then grew by 1.32% to $6.6 billion in 2024, then grew by 10.47% to $7.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Buildings are $7.3 billion (Q4 2025), $7.1 billion (Q3 2025), and $6.9 billion (Q2 2025).